QL301, a PD-L1 dependent 4-1BB agonist with enhanced preclinical anti-tumor efficacy and minimal liver toxicityKyungjin Park,Yangsoon Lee, Saeyi Lim,Kyeongsu Park,Eunjung Kim,Hanbyul Lee,Jiseon Yoo, Youngdon Pak,Yeunju Kim,Minji Ko,Jonghwa WonCANCER RESEARCH(2022)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要